Literature DB >> 4778382

Lipid and fatty acid composition of myelin purified from normal and MS brains.

H Woelk, P Borri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4778382     DOI： 10.1159/000114281

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  13 in total

1.  [On the activity of phospholipase A2 compared with 1-alk-1'-enyl-2-acyl- and 1-alkyl-2-acyl-glycerophosphatides in multiple sclerosis (author's transl)].

Authors:  H Woelk; K Peiler-Ichikawa
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

Review 2.  Is the myelin membrane abnormal in multiple sclerosis?

Authors:  D D Wood; M A Moscarello
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

3.  [The glycerophospholipid content of the white matter of normal and MS brains (author's transl)].

Authors:  M Winterfeld; H Debuch
Journal:  J Neurol       Date:  1977-07-20       Impact factor: 4.849

4.  Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

Authors:  Robert K McNamara; Therese Rider; Ronald Jandacek; Patrick Tso
Journal:  Psychiatry Res       Date:  2014-01-02       Impact factor: 3.222

5.  Erythrocyte antioxidant enzymes in multiple sclerosis and the effect of hyperbaric oxygen.

Authors:  M I Hunter; M S Lao; S S Burtles; D L Davidson
Journal:  Neurochem Res       Date:  1984-04       Impact factor: 3.996

6.  The fatty acid composition of major glycosphingolipids (cerebrosides and sulfatides) in human cerebral white matter measured by a simple micromethod.

Authors:  R Heipertz; H Pilz; W Scholz
Journal:  J Neurol       Date:  1976-07-15       Impact factor: 4.849

7.  On the effect of brain phospholipase A1 on specifically labelled glycerophospholipids in the course of subacute sclerosing panencephalitis.

Authors:  U J Morgott; H Woelk
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

8.  Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

Authors:  M I Hunter; B C Nlemadim; D L Davidson
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

9.  Comparison of two molecular species of ethanolamine plasmalogen in multiple sclerosis and normal myelin.

Authors:  J M Boggs; D Stamp; M A Moscarello
Journal:  Neurochem Res       Date:  1982-08       Impact factor: 3.996

10.  A comparison of composition and fluidity of multiple sclerosis and normal myelin.

Authors:  J M Boggs; M A Moscarello
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.